Clinical Trial Update: Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the combination of rt-PA with edaravone dexborneol for acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Edaravone Dexborneol
• rt-PA (tissue plasminogen activator)

Snippet

Sponsor: The Second Hospital of Hebei Medical University | Conditions: Acute Ischemic Stroke | Phase 4 | Status: UNKNOWN